Jorn Aldag, now CEO of uniQure, spoke at the World Orphan Drug USA in 2011. He was then CEO of AMT.
These are the slides from his presentation 'Designing innovative clinical trials to expedite market approval.' In his presentation, Jorn looks at a few rare diseases, including Progeria and Lipoprotein Lipase Deficiency.
Download the slides for more information.